Evidence map›Paper›PMID 38954225›Full record

ReviewPaediatric drugs2024

A Narrative Review of Pain in Pediatric Oncology: The Opioid Option.

Elizabeth A Hall, Tracy M Hagemann, Chasity M Shelton, Hilary M Jasmin, Alexis N Calvasina, Doralina L Anghelescu

Abstract readReview
In one paragraph

Review in Paediatric drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth A HallDepartment of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, TN, USA. liz.hall@uthsc.edu.ORCID http://orcid.org/0000-0002-8545-6917
Tracy M HagemannDepartment of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-5715-9173
Chasity M SheltonDepartment of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-9141-3617
Hilary M JasminHealth Sciences Library, University of Tennessee Health Science Center, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-5115-1365
Alexis N CalvasinaCollege of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.ORCID http://orcid.org/0009-0009-0451-7182
Doralina L AnghelescuDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-8521-2744

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioid therapy is the mainstay for managing pain in pediatric oncology. This narrative review describes the current literature regarding opioids for pediatric cancer pain. The review explores the multifaceted landscape of opioid utilization in this population, including the role of opioids in certain clinical circumstances, modalities of opioid delivery, unique opioids, outpatient and at-home pain management strategies, and other key concepts such as breakthrough pain. This review highlights the importance of individualized dosing and multimodal approaches to enhance efficacy and minimize adverse effects. Drawing from a wide range of evidence, this review offers insights to optimize pediatric oncology pain management.

Indexed as

Analgesics, OpioidCancer PainPain ManagementChildHumansMedical OncologyNeoplasmsPainPediatricsAnalgesics, Opioid

Identifiers

PMID38954225
PMCPMC11335799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.